Statement of Licensing Status

Apply for a Statement of Licensing Status.

Overview

The Statement of Licensing Status (SLS) attests a specified therapeutic product has been registered for use in Singapore. It is usually intended to facilitate the screening and preparation of product information by importing agents when considering bids made in response to an international tender.

The SLS provides details pertaining to the therapeutic product such as:

  • Name
  • Dosage form
  • Composition
  • Product registration number

The SLS will be issued in the format as recommended by the World Health Organization.

With effect from 25 March 2026, HSA will be issuing verifiable electronic certificates for exporters (including Certificate of a Pharmaceutical Product and Free Sale Certificate) using GovTech’s FileSG digital platform. FileSG will replace TrustDocs for issuance of verifiable electronic documents. There will not be any changes to the application process, regulatory requirements and application fees for these certificates. For further information, please refer to the HSA Frequently Asked Questions on Migration of TrustDocs to FileSG.

Documents required

You will need the following supporting documents to complete your application:

  • Latest local sales invoice, if applicable.
  • Other supporting documents, if applicable.

Fees and turnaround time 

Refer to therapeutic product fees and turnaround time for more information.

How to apply

Submit your application through PRISM. Ensure you have the following before you access the e-service:

If you encounter technical issues, e-mail the HSA helpdesk or call 6776 0168 (from 7.00 am to midnight daily).